Charles Halpern Letter to ICOC
By Charles Halpern
| 01. 03. 2005
Dear Members of the ICOC:
I reviewed the agenda for the January 6 meeting with concern and surprise. I find that the Bagley-Keene Open Meetings Act is still not being complied with and that the Committee is being invited to rush into the core of its work without having laid an appropriate foundation.
I write to encourage you to take charge of the mission of the Institute and to begin to function as a deliberative body, allowing due time for serious consideration of complex issues, with public involvement in the manner prescribed by California law.
I suggest that the ICOC take the following steps:
1. Clarify the scope of the program.
Though there is an unfortunate ambiguity in the intertwined provisions of Prop. 71, it is clear that the Institute for Regenerative Medicine is not limited to supporting embryonic stem cell research. It is authorized to support a broad range of medical research intended to cure or mitigate disease. How will the ICOC define the mandate? Will the construction grants that are likely to loom large in the first year's...
Related Articles
By Staff, National Women's Law Center | 08.13.2025
INTRODUCTION
Baby bonuses. Motherhood medals. Fertility tracking. You may have heard of these policy proposals as solutions from the Trump administration to help encourage women to have more children.
Besides falling short of ensuring that people have what they need...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Cade Metz, The New York Times | 08.04.2025
Image by Mike MacKenzie / CC BY 2.0
In downtown Berkeley, an old hotel has become a temple to the pursuit of artificial intelligence and the future of humanity. Its name is Lighthaven.
Covering much of a city block, this...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...